Overall market situation:
Sentiment during the last trading session in Europe this week is mixed. The German DAX is currently losing 0.8%, while the British FTSE100 is adding 0.85%. Volatility remains high, which indicates that the pressure from the US-China trade war is still creating uncertain ground for future stock market behavior. For this reason, any new comments on this issue may increase the dynamics of changes in the prices of financial instruments in the near future.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app
Distribution of today's rates of return of companies from Europe. Source: xStation
The German DE40 index is losing 1.7% today on an intraday basis. The key element in analyzing the further, potential behavior of the index may be the element of further behavior of demand and supply at the previously tested barrier of 20,000 points, which may decide whether the further downward trend will continue. Source: xStation
News:
Novartis AG (NOVN.CH) plans to invest $23 billion in the U.S. over the next five years to ensure its key medicines for Americans are produced in the country.
The investment will fund seven new facilities, including a research facility in California and six manufacturing plants, and will expand three existing facilities in the U.S., creating 1,000 jobs.
Gerresheimer (GXI.DE) shares are up 2.5% after the company reported its first-quarter results. Adjusted EBITDA from the plastics and devices business was EUR 63.4 million, compared to estimates of EUR 63.5 million. Revenue from the plastics and devices business was EUR 294.5 million, compared to expectations of EUR 284.4 million. Gerresheimer predicts organic revenue growth of 3%-5% in 2025 and an adjusted EBITDA margin of 22%.
Upgrades:
- Raiffeisen upgraded to buy at Erste Group; PT €29
K+S upgraded to hold at Stifel; PT €14.50
Downgrades:
- BP downgraded to neutral at UBS
Lanxess downgraded to sell at Goldman
HelloFresh downgraded to neutral at JPMorgan; PT €9
Other news from DAX companies. Source: Bloomberg Financial LP
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
